"Bypassing its standard pathways for scientific discussions, FDA has recently held a slew of so-called "expert panels" that sidestep legal procedures and ethics guardrails, raising concern about cherry-picking of experts and evidence.
The panels appear to be a new feature of Trump administration officials, and have no parallel in agency programs from years past, sources said."
https://www.medpagetoday.com/washington-watch/fdageneral/116662
